Real-World Treatment Patterns and Health-Resource Utilization in Patients with Hepatocellular Carcinoma (HCC) Following Failure of Sorafenib: A Retrospective Chart Review of 127 Patients in South Korea

BACKGROUND: European, US, Asian and Korean treatment guidelines all recommend sorafenib as first-line systemic therapy in patients with hepatocellular carcinoma (HCC). However, due to the emergence of several new treatments, post-sorafenib treatment patterns in real-world clinical practice are less...

Descripción completa

Detalles Bibliográficos
Autores principales: Novick, Diego, Cho, Jae Min, Colman, Sam, Szende, Agota
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114252/
https://www.ncbi.nlm.nih.gov/pubmed/34905182
http://dx.doi.org/10.1007/s40801-021-00286-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114252/
https://www.ncbi.nlm.nih.gov/pubmed/34905182
http://dx.doi.org/10.1007/s40801-021-00286-z

Ejemplares similares